A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma
- Francine Foss
- , Ranjana Advani
- , Madeleine Duvic
- , Kenneth B. Hymes
- , Tanin Intragumtornchai
- , Arnuparp Lekhakula
- , Ofer Shpilberg
- , Adam Lerner
- , Robert J. Belt
- , Eric D. Jacobsen
- , Guy Laurent
- , Dina Ben-Yehuda
- , Marie Beylot-Barry
- , Uwe Hillen
- , Poul Knoblauch
- , Gajanan Bhat
- , Shanta Chawla
- , Lee F. Allen
- , Brad Pohlman
Research output: Contribution to journal › Article › peer-review
184
Scopus
citations